According to Voyager Therapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ1.89. In 2022 the company made an earnings per share (EPS) of -ยฃ0.95 an increase over its 2021 EPS that were of -ยฃ1.50.
Year | EPS | Change |
---|---|---|
2023 (TTM) | ยฃ1.97 | -305.82% |
2022 | -ยฃ0.95 | -36.32% |
2021 | -ยฃ1.50 | -293.88% |
2020 | ยฃ0.77 | -177.78% |
2019 | -ยฃ0.99 | -54.35% |
2018 | -ยฃ2.18 | 3.37% |
2017 | -ยฃ2.11 | 68.99% |
2016 | -ยฃ1.25 | -26.71% |
2015 | -ยฃ1.70 |